The Advisory Committee is an esteemed group of industry thought leaders assembled by BIO to shape this event’s conference program by collaboratively identifying topics and speakers that will facilitate engaging and informative discussions.
Lindsay Androski
President and CEO, Roivant Social Ventures
President and CEO, Roivant Social Ventures
Gad Berdugo
Founder and Managing Partner, Explorium Capital LLC
Founder and Managing Partner, Explorium Capital LLC
Alan Chiu, PhD
Industry Investments, Breakthrough T1D
Michelle Doig
Partner, Head of Corporate Development, Omega Funds
Partner, Head of Corporate Development, Omega Funds
Kate Haviland
CEO, Blueprint Medicines
CEO, Blueprint Medicines
Jennifer Hawks Bland
CEO, NewYorkBIO
CEO, NewYorkBIO
Darren Ji, MD, PhD, MBA
Co-Founder, Chairman, Chief Executive Officer, Elpiscience
Co-Founder, Chairman, Chief Executive Officer, Elpiscience
Anna Kazanchyan, MD
Chairwoman and CEO, Saghmos Therapeutics
Evan Loh, MD
CEO, Paratek
CEO, Paratek
Glennis Mehra, PhD
Director, BioLabs New York
Director, BioLabs New York
Sara Nayeem, MD
Executive Vice President, Investment, Enavate Sciences
Executive Vice President, Investment, Enavate Sciences
Kimberly Nearing
Venture Partner, BVCF
Dennis Purcell
Founder and Senior Advisor, Aisling Capital
Founder and Senior Advisor, Aisling Capital
Lynn Seely, MD
President and CEO, Lyell
President and CEO, Lyell
Philip S. Ross
Chairman Global Healthcare Investment Banking, Jefferies
Chairman Global Healthcare Investment Banking, Jefferies
Mahendra Shah, PhD
Senior Fellow, Vivo Capital
Senior Fellow, Vivo Capital
Jennifer Sheng
Managing Director, Citi
Managing Director, Citi
R. Nolan Townsend
CEO, Lexeo Therapeutics
CEO, Lexeo Therapeutics
Alethia Young
CFO, Bicycle Therapeutics
CFO, Bicycle Therapeutics
)
){kind=logo}
)
){kind=logo}
){kind=logo}